Home/Orlance/Ken Bagley
KB

Ken Bagley

Director R&D

Orlance

Orlance Pipeline

DrugIndicationPhase
Universal Influenza VaccineInfluenzaPre-IND
Enhanced Seasonal Influenza VaccineInfluenzaResearch
Chronic Hepatitis B VaccineHepatitis BResearch
Neoantigen Cancer Vaccine PlatformOncologyResearch